Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.39B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$790M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$648M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$411M |
| 5 |
Microsoft
MSFT
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$344M |
| 2 |
Consolidated Edison
ED
|
+$155M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$154M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$146M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.52% |
| 2 | Financials | 5.73% |
| 3 | Healthcare | 5.63% |
| 4 | Communication Services | 4.65% |
| 5 | Consumer Discretionary | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5376
PUT
Canadian National Railway
CNI
$77B
| $130K | ﹤0.01% |
1,400
-15,300
| -92% | -$1.41M |
|
5377
Cytosorbents Corp
CTSO
$23.7M
| $130K | ﹤0.01% |
19,740
-1,265
| -6% | -$8.69K |
|
5378
First Bank
FRBA
$468M
| $130K | ﹤0.01% |
11,051
+5,754
| +109% | +$65.4K |
|
5379
CALL
Gold Fields
GFI
$30.5B
| $130K | ﹤0.01% |
24,100
+11,000
| +84% | +$47K |
|
|
ABMD
5380
CALL
DELISTED
Abiomed Inc
ABMD
| $130K | ﹤0.01% |
500
-9,900
| -95% | -$2.63M |
|
|
HBMD
5381
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $130K | ﹤0.01% |
8,595
+4,732
| +122% | +$67.2K |
|
|
PFNX
5382
DELISTED
Pfenex Inc.
PFNX
| $130K | ﹤0.01% |
19,233
+11,190
| +139% | +$71.5K |
|
5383
Alpha and Omega Semiconductor
AOSL
$1.01B
| $129K | ﹤0.01% |
13,722
+4,665
| +52% | +$48.6K |
|
5384
BCB Bancorp
BCBP
$159M
| $129K | ﹤0.01% |
9,281
+4,285
| +86% | +$55K |
|
5385
PUT
Cedar Fair
FUN
$1.85B
| $129K | ﹤0.01% |
2,700
+2,600
| +2,600% | +$135K |
|
5386
CALL
iShares North American Natural Resources ETF
IGE
$750M
| $129K | ﹤0.01% |
4,200
+2,600
| +163% | +$79.5K |
|
5387
NatWest
NWG
$76.1B
| $129K | ﹤0.01% |
+21,057
| New | +$138K |
|
5388
Surgery Partners
SGRY
$2.05B
| $129K | ﹤0.01% |
15,862
-3,067
| -16% | -$30.6K |
|
|
XONE
5389
DELISTED
The ExOne Company
XONE
| $129K | ﹤0.01% |
13,804
-87,215
| -86% | -$719K |
|
|
CBMG
5390
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $129K | ﹤0.01% |
7,799
+4,445
| +133% | +$72.6K |
|
5391
Graham Corp
GHM
$1.23B
| $128K | ﹤0.01% |
6,353
+2,895
| +84% | +$59.5K |
|
5392
CALL
Global Payments
GPN
$24.1B
| $128K | ﹤0.01% |
800
-400
| -33% | -$59.5K |
|
5393
iShares Russell 2000 Growth ETF
IWO
$15B
| $128K | ﹤0.01% |
639
-800
| -56% | -$158K |
|
5394
NACCO Industries
NC
$360M
| $128K | ﹤0.01% |
2,474
+1,280
| +107% | +$59.8K |
|
5395
Talphera
TLPH
$70.6M
| $128K | ﹤0.01% |
2,532
-6,177
| -71% | -$371K |
|
|
IHC
5396
DELISTED
Independence Holding Company
IHC
| $128K | ﹤0.01% |
3,305
+1,836
| +125% | +$68.1K |
|
5397
Bankwell Financial Group
BWFG
$537M
| $127K | ﹤0.01% |
4,424
+2,585
| +141% | +$75.7K |
|
5398
Evolution Petroleum
EPM
$127M
| $127K | ﹤0.01% |
17,822
+9,918
| +125% | +$67K |
|
5399
Stratus Properties
STRS
$160M
| $127K | ﹤0.01% |
3,907
+2,109
| +117% | +$56.7K |
|
5400
PUT
Valmont Industries
VMI
$9.72B
| $127K | ﹤0.01% |
1,000
| – | – |
|
Similar funds
Barclays's Q2 2019 Portfolio in Review
As of Q2 2019, Barclays held 7,617 positions worth $163B, up 13% from $145B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $14.2B of net new capital in Q2 2019, opening 457 new positions and adding to 3,922 existing holdings. Its largest new stake was Dow Inc: 2,580,874 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $344M trimmed.
- Barclays's largest Q2 2019 buy was Dow Inc: 2,580,874 shares worth $127M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $1.39B increase.
- Barclays's biggest Q2 2019 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $344M.
- Barclays fully exited Bemis in Q2 2019, selling an estimated $33.4M.
- Barclays's ten largest holdings make up 25% of its $163B portfolio in Q2 2019.
- Barclays opened 457 new positions and closed 572 in Q2 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.